RxDoctor Payments Data

Hannah Anzalone, PA

Physician Assistant · Covington, LANPI 1730793787

Payments from drug & device makers

$1,314in general payments, 2019–2025

Across 82 payments — averaging $16.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$359
  • Biohaven Pharmaceuticals, Inc.$157
  • AbbVie$154
  • Neurelis, Inc.$146
  • SK Life Science, Inc.$83
  • Lilly USA, LLC$69
  • plus $346 from 13 others

What the payments were for

  • Food & beverage$1,314100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,314 in reported general payments places this provider in the 70th percentile of 1,246 physician assistant providers in Louisiana.

See all physician assistant providers in Louisiana

Medicare billing

Part B allowed, 2024
$33,446
Medicare patients
288
Services billed
498

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide97$135,984
OzempicSemaglutide105$124,590
JardianceEmpagliflozin68$65,280
EliquisApixaban72$52,688
JanuviaSitagliptin Phosphate40$30,078
TrulicityDulaglutide19$23,447
FarxigaDapagliflozin Propanediol30$23,022
LinzessLinaclotide32$19,153
XareltoRivaroxaban16$9,975
MyrbetriqMirabegron11$7,478
Albuterol Sulfate HfaAlbuterol Sulfate105$3,663
Lantus SolostarInsulin Glargine,hum.Rec.Anlog19$3,605
Gabapentin223$3,441
Rosuvastatin Calcium191$2,608
Atorvastatin Calcium200$2,372

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$69$159,431116 claims
AstraZenecaFarxiga$30$23,02230 claims
AbbVieLinzess, Synthroid$154$20,05044 claims
Johnson & JohnsonXarelto$21$9,97516 claims
Astellas Pharma US IncMyrbetriq$14$7,47811 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$14$1,815193 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 1,246 physician assistant providers in Louisiana.

Other physician assistant in Covington

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →